Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

10.51B

Market cap10.51B

Price-Earnings ratio

-2.93

Price-Earnings ratio-2.93

Dividend yield

—

Dividend yield—

Average volume

6.95M

Average volume6.95M

High today

$27.87

High today$27.87

Low today

$26.62

Low today$26.62

Open price

$26.83

Open price$26.83

Volume

7.72M

Volume7.72M

52 Week high

$170.47

52 Week high$170.47

52 Week low

$23.15

52 Week low$23.15

MRNA News

Simply Wall St 3d

Moderna (NasdaqGS:MRNA) Sees 11% Share Price Surge Over Last Week

experienced a 10% share price increase, coinciding with broader market gains but slightly below the Nasdaq Composite's 5% rise. Despite the market being uplifte...

TipRanks 4d

Moderna price target lowered to $26 from $32 at BofA

BofA lowered the firm’s price target on Moderna (MRNA) to $26 from $32 and keeps an Underperform rating on the shares. For 2025, the firm’s revenue forecast dec...

Analyst ratings

66%

of 29 ratings

Buy

20.7%

Hold

65.5%

Sell

13.8%